54Gene, Inc. — Form D
54Gene, Inc. of WASHINGTON, DC, a company, filed a Form D exempt-offering notice with the SEC on 2021-09-24. The offering totals $37.5M, of which $25.1M was reported sold. Industry: Other Technology.
Offering
- Filed: 2021-09-24
- Form: D
- Accession: 0001809111-21-000004
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $37.5M
- Amount sold: $25.1M
- Remaining: $12.4M
- Investors: 27
- Date of first sale: 2021-09-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-414541
Issuer
- Name: 54Gene, Inc.
- CIK: 0001809111
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 1100 15TH STREET, NW, WASHINGTON, DC, 20005
- Phone: (202) 294-2955
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Delali Attipoe | Director | WASHINGTON, DC |
| Abasi Ene-Obong | Director | WASHINGTON, DC |
| PATRICE Falusi MILOS | Director | WASHINGTON, DC |
| Olufunmilayo Falusi Olopade | Director | WASHINGTON, DC |
| YASSINE Falusi OUSSAIFI | Director | WASHINGTON, DC |
| Jenny Yip | Director | BRISBANE, CA |
| Delali Attipoe | Executive Officer | WASHINGTON, DC |
| Abasi Ene-Obong | Executive Officer | WASHINGTON, DC |
| Abasi Ene-Obong | Promoter | WASHINGTON, DC |
Other filings by this issuer (1)
More